FOx BIOSYSTEMS uses innovative fiber-optic based surface plasmon resonance biosensor technology to provide flexibility and control to your bioanalysis.
Location: Netherlands, Limburg, Maastricht
Total raised: $8.95M
Investors 2
| Date | Name | Website |
| - | Heran Part... | heranpartn... |
| - | KU Leuven ... | lrd.kuleuv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.01.2023 | Series B | $6.29M | - |
| 20.12.2022 | Grant | $2.66M | - |
Mentions in press and media 8
| Date | Title | Description |
| 02.10.2024 | Revolutionizing Biomarker Development: Automated Detection and Isolation of Extracellular Vesicles, Upcoming Webinar Hosted by Xtalks | www.foxbiosystems.com In this free webinar, learn about a one-step automated method for affinity-specific detection, quantification and isolation of extracellular vesicles for downstream analysis, which would lead to unbiased and reproducib... |
| 06.06.2024 | Protein Quantitation and Binding Kinetics Analysis: A Guide for Everyone, Upcoming Webinar Hosted by Xtalks | www.foxbiosystems.com In this webinar, learn about rapid, reliable protein quantitation and kinetic binding data analysis. Attendees will explore the ease of performing kinetic interaction experiments, including versatility in handling vari... |
| 05.09.2023 | FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO | Diepenbeek, Belgium, September 5th, 2023 |
| 14.04.2023 | Discover how a sound collaboration between a start-up and a Venture Capital fund drives innovation in healthcare: FOx Biosystems case study | Data processing, speed, and efficiency are of key importance in the field of pharmacological research. The importance of these factors was evident during the development of the first COVID-19 vaccines. With their White FOx technology, FOx B... |
| 13.01.2023 | FOx BIOSYSTEMS raises €5,8 million in a Series B-round | Diepenbeek, Belgium |
| 20.12.2022 | FOx BIOSYSTEMS receives €2,5 million EIC grant | |
| 19.03.2021 | Announcing the launch of the White FOx | FOx BIOSYSTEMS, one of HERAN Partner's portfolio companies, is breaking the limits in bioanalysis. With our fund: HERAN HealthTech Fund I, we are committed to investing in entrepreneurs that add significant value to healthcare. That's why w... |
| 01.09.2020 | FOx Biosystems appoints Thomas van Elzakker as its new CEO | Diepenbeek (Belgium), September 1st, 2020 – FOx Biosystems’ Board of Directors announces the appointment of Thomas van Elzakker as Chief Executive Officer per 1 September 2020. Van Elzakker takes over from company co-founder Filip Delport w... |